Inhaled insulin

by diabetes.co.uk
Good news for more than 2 million diabetes sufferers. Insulin injections could be a thing of the past in less than a year reports Diabetes UK, as inhaled insulin is set to become a reality for more than 700, 000 people using insulin every day in the UK alone.
UK welcomes the news that the US Food and Drug Administration (FDA) advisory committee has recommended approval of the inhaled insulin Exubera, which does away with painful injections.
This is especially good news for parents with diabetic children, who have to endure the struggle when administrating painful injections every day.
Both UK and US trials into the use of Exubera insulin for adults with Type 1 and Type 2 diabetes have already shown it works with no serious side effects. However some concern has been expressed about the long-tem effect of the drug and its manufacturers, Pfizer, Sanofi Aventis and Nektar Therapeutics are now conducting trials to check there are no side affects in the long run.
Although Inhaled insulin is not yet licensed for use, applications have been made with the European Medicines Evaluation Agency . If Exubera does get the go ahead then it will be an answer to many peoples prayers.